(HealthDay News) — The new Omicron subvariant, BA.2, is spreading across the United States and will soon take over as the major COVID variant, White House chief medical adviser Dr. Anthony Fauci said Tuesday. “Ultimately it will be the predominant variant in this country,” Fauci told HealthDay. “It’s occupying about 85% of the variants in… read on > read on >
Millions of people taking statin drugs to lower their cholesterol may get an unanticipated benefit: They may be less likely to develop movement and balance problems like those seen in Parkinson’s disease, a new study suggests. The study looked at the relationship between statin use and parkinsonism. People with parkinsonism have some of the symptoms… read on > read on >
As coronavirus hospitalizations and deaths drop across the United States, the chief executives of the country’s largest airlines have asked President Joe Biden to let a federal mask mandate at airports and on planes to lapse next month. Also included in the request is the dropping of COVID testing for international travelers arriving in the… read on > read on >
Men are more likely than women to be offered surgery to ease carpal tunnel syndrome, but a small new study from one hospital suggests that gender may have nothing to do with the disparity. Instead, the difference may exist because the condition tends to be more severe in men, the researchers said. Carpal tunnel syndrome… read on > read on >
Lying facedown may improve breathing in COVID-19 patients who are awake, but many can’t stay in a prone position long enough to reap the benefit, a new study finds. Prone positioning is standard for patients with severe acute respiratory distress syndrome (ARDS), because it encourages a larger part of the lung to expand, so patients… read on > read on >
Recovering from hip or knee replacement surgery can be tough for anyone, but a new study from one hospital showed that Black patients were less likely than white patients to be satisfied with their care after the procedure. Researchers reviewed survey responses from more than 2,500 people who underwent hip replacement and more than 2,100… read on > read on >
A lower dose of a widely used COVID-19 drug is just as effective as a higher dose, new research shows. Tocilizumab (Actemra) is a rheumatoid arthritis drug that has become the standard of care for treating severe COVID-19, but high demand and production limitations have prompted shortages of the medication in many countries. These findings… read on > read on >
Your 30s can be a magical time filled with career strides, vacations you can actually afford, love, marriage and even a growing family of your own. It’s likely not the decade where you begin to fret about your risk for developing Alzheimer’s disease in the future. But maybe it should be. This is the main… read on > read on >
Moderna announced Wednesday that it will ask the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine for children under 6. The company said that its request is based on interim results from its clinical trial that showed, even when given a dose that was one-quarter as strong as the… read on > read on >
WEDNESDAY, March 23, 2022 (American Heart Association News) — Stroke survivors may have a higher risk of developing depression or another mood disorder within the first year, according to new research that compared their risk to the general public as well as people who survived a heart attack. Past research shows depression is common after… read on > read on >
